Pathogenetic role of nitrosative and oxidative stress in the development of anemia of inflammation in young children
Background. The purpose was to study the pathogenetic role of nitrosative and oxidative stress in the occurrence of anemia of inflammation in young children. Materials and methods. The content of nitrotyrosine and phospholipase A2 in the blood serum of 55 young children (the average age of 1.6 ± 0.3 years) was determined by the method of enzyme-linked immunosorbent assay. The basic group consisted of 30 children with acute bacterial diseases of the respiratory tract: 21 patients were diagnosed with acute bacterial bronchitis, and 9 children — with community-acquired pneumonia. The basic group was divided into two subgroups: the first subgroup consisted of 15 children with anemia of inflammation, the second subgroup — 15 children with acute bacterial diseases of the respiratory tract without anemia manifestation. The comparison group included 10 children with iron deficiency anemia without manifestations of inflammatory diseases of the respiratory system. Fifteen apparently healthy children represented the control group. Results. It was found that anemia of inflammation in children is accompanied by the activation of nitrosative and oxidative stress as evidenced by high nitrotyrosine content (63.3 ± 4.7 ng/ml), which was 5 times greater than in the control group (12.5 ± 1.6 ng/ml) (p < 0.01) and phospholipase A2 level (6.1 ± 0.7 ng/ml), which was 2.3 times higher than in the control group (2.28 ± 0.40 ng/ml) (p < 0.05). The positive correlation was determined between the severity of bacterial inflammatory disease and the activation of nitrosative and oxidative stress (r = 0.7, p < 0.001). Conclusions. The activation of oxygen-containing and nitrogen-containing metabolites against the background of infectious and inflammatory disease induces the development of nitrosative and oxidative stress, which play an important role in the pathogenesis of anemia of inflammation in young children with acute bacterial respiratory diseases.
Ricciardolo FL, Caramori G, Ito K, et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2005 Nov;116(5):1028-35. doi: 10.1016/j.jaci.2005.06.034.
Louhelainen N, Myllärniemi M, Rahman I, Kinnula VL. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis. 2008;3(4):585-603. doi: 10.2147/copd.s3671.
Tsvetikova LN, Bugrimov DYu, Lobeeva NV. Metabolic factors of pathological conditions formation associated with oxidative status changes. Zhurnal anatomii i gistopatologii. 2015;4(2):14-22. doi: 10.18499/2225-7357-2015-4-2-14-22. (in Russian).
Aresti Sanz J, El Aidy S. Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response. Psychopharmacology (Berl). 2019 May;236(5):1597-1609. doi: 10.1007/s00213-019-05224-0.
Shimizu T, Tomioka H. Novel type of antimicrobial mechanism in host macrophages against mycobacterial infections. Nihon Hansenbyo Gakkai Zasshi. 2009 Sep;78(3):283-91. doi: 10.5025/hansen.78.283. (in Japanese).
Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013 Dec;65:1174-1194. doi: 10.1016/j.freeradbiomed.2013.09.001.
Sugiura H, Ichinose M, Tomaki M, et al. Quantitative assessment of protein-bound tyrosine nitration in airway secretions from patients with inflammatory airway disease. Free Radic Res. 2004 Jan;38(1):49-57. doi: 10.1080/10715760310001633817.
Connelly L, Madhani M, Hobbs AJ. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice a proinflammatory role for eNOS-derived no in vivo. J Biol Chem. 2005 Mar 18;280(11):10040-6. doi: 10.1074/jbc.M411991200.
Oved K, Cohen A, Boico O, et al. A novel host-proteome signature for istinguishing between acute bacterial and viral infections. PLoS One. 2015 Mar 18;10(3):e0120012. doi: 10.1371/journal.pone.0120012.
Macdonald DJ, Boyle RM, Glen AC, Leslie CC, Glen AI, Horrobin DF. The development of an ELISA for group IVA phospholipase A2 in human red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2015 Mar;94:43-8. doi: 10.1016/j.plefa.2014.11.003.
Copyright (c) 2020 CHILD`S HEALTH
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019